Stay updated with breaking news from Nasdaq Cstl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) was the recipient of a significant growth in short interest in January. As of January 15th, there was short interest totalling 958,800 shares, a growth of 19.8% from the December 31st total of 800,300 shares. Based on an average trading volume of 257,000 shares, the days-to-cover ratio […]
Bank Pictet & Cie Europe AG boosted its stake in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 14.8% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 14,079 shares of the company’s stock after acquiring an additional 1,813 shares during the […]
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) insider Derek J. Maetzold sold 5,201 shares of the stock in a transaction that occurred on Wednesday, December 20th. The shares were sold at an average price of $21.05, for a total value of $109,481.05. Following the completion of the sale, the insider now directly owns 97,517 […]
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) was the recipient of a significant decrease in short interest during the month of November. As of November 30th, there was short interest totalling 1,180,000 shares, a decrease of 9.2% from the November 15th total of 1,300,000 shares. Based on an average daily trading volume, of 253,300 […]
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) Director Daniel Bradbury sold 6,875 shares of the company’s stock in a transaction that occurred on Friday, December 8th. The shares were sold at an average price of $20.09, for a total transaction of $138,118.75. Following the completion of the sale, the director now directly owns 50,605 […]